Dual function of Lactobacillus kefiri DH5 in preventing high‐fat‐diet‐induced obesity: direct reduction of cholesterol and upregulation of PPAR‐α in adipose tissue
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Scope: Kefir consumption inhibits the development of obesity and non‐alcoholic fatty liver disease (NALFD) in mice fed 60% high‐fat diet (HFD). To identify the key contributor of this effect, we isolated lactic acid bacteria (LAB) from kefir and examined their anti‐obesity properties from in vitro screening and in vivo validation. Methods and results: Thirteen kefir LAB isolates were subjected to survivability test using artificial gastrointestinal environment and cholesterol‐reducing assay. Lactobacillus kefiri DH5 showed 100% survivability in gastrointestinal environments and reduced 51.6% of cholesterol; thus, this strain was selected for in vivo experiment. Compared to the HFD‐saline group, the HFD‐DH5 group showed significantly lower body weight (34.68 versus 31.10 g; p < 0.001), epididymal adipose tissue weight (1.39 versus 1.05 g; p < 0.001), blood triglyceride (38.2 versus 31.0 mg/dL; p < 0.01) and LDL‐cholesterol levels (19.4 versus 15.7 mg/dL; p < 0.01). In addition, L. kefiri DH5 administration significantly modulated gut microbiota of HFD‐fed mice. The hepatic steatosis was significantly milder (Lesion score, 2.1 versus 1.2; p < 0.001) and adipocyte diameter was significantly smaller (65.1 versus 42.2 μm; p < 0.001) in the HFD‐DH5 group. L. kefiri DH5 upregulated PPAR‐α, FABP4, and CPT1 expression in the epididymal adipose tissues (2.29‐, 1.77‐, and 2.05‐fold change, respectively), suggesting a reduction in adiposity by stimulating fatty acid oxidation. Conclusion: L. kefiri DH5 exerts anti‐obesity effects by direct reduction of cholesterol in the lumen and upregulation of PPAR‐α gene in adipose tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Lactobacillus kefiri DH5 strain was able to decrease body weight, adipose tissue and plasma lipid parameters, acting through the reduction of cholesterol in the intestinal lumen and the upregulation of PPARα in adipose tissue.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [33]
In the citing paper
“The Lactobacillus kefiri DH5 strain was able to decrease body weight, adipose tissue and plasma lipid parameters, acting through the reduction of cholesterol in the intestinal lumen and the upregulation of PPARα in adipose tissue.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [33]
In the citing paper
“These results indicate that Lactobacillus kefiri DH5 is a potential probiotic strain for the treatment of obesity (33).”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [33]
In the citing paper
“Moreover, the animals that consumed this strain presented a variation in the composition of their intestinal microbiota, with a lower number of Proteobacteria and Enterobacteriaceae, when compared to the non-supplemented animals.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [33]
In the citing paper
“In addition to its effect on obesity, the consumption of Lactobacillus kefiri DH5 presented a hepatoprotective effect.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,182
Determination of cholesterol using o-phthalaldehyde
Rudel, L. L., & Morris, M. D. (1973) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36896-6 · Cited by 1,043
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
Gut microbiome, obesity, and metabolic dysfunction
Tilg, H., & Kaser, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58109 · Cited by 860
Fatty acid metabolism: Target for metabolic syndrome
Wakil, S. J., & Abu-Elheiga, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800079-jlr200 · Cited by 731
Metabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712
Thelaus, J., Forsman, M., & Andersson, A. (2008) · Microbial Ecology · doi:10.1007/s00248-007-9320-4 · Cited by 610
Contribution of diet to the composition of the human gut microbiota
Graf, D., Di Cagno, R., Fåk, F., Flint, H. J., Nyman, M., Saarela, M., & Watzl, B. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26164 · Cited by 519
Handbook of Fermented Functional Foods
(2003) · CRC Press eBooks · doi:10.1201/9780203009727 · Cited by 434
Cited by
Items 101–128 of 128
Sex-dependent effects of a yoghurt enriched with proteins in a mouse model of diet-induced obesity
Siroli, L., Burns, P., Borgo, F., Puntillo, M. A., Drago, S. R., Forzani, L., D’Alessandro, M. E., Reinheimer, J. A., Perotti, M. C., & Vinderola, G. (2020) · International Dairy Journal · doi:10.1016/j.idairyj.2020.104914 · Cited by 7
Cai, W., Li, Z., Huang, W., Zhou, M., Liu, H., Yang, Y., Tan, B., & Dong, X. (2025) · Aquaculture Reports · doi:10.1016/j.aqrep.2025.102736 · Cited by 10
Mutalub, Y. B., Azemi, A. K., Suhaimi, S. Q. A., Rasool, A. H. G., Tang, S. P., Lee, C., & Mokhtar, S. S. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106802 · Cited by 5
Novel Low-Alcohol Sangria-Type Wine Products with Immobilized Kefir Cultures and Essential Oils
Nikolaou, A., Santarmaki, V., Mitropoulou, G., Sgouros, G., & Kourkoutas, Y. (2023) · Microbiology Research · doi:10.3390/microbiolres14020038 · Cited by 5
Falalyeyeva, T. M., Kobyliak, N. M., Korotkyi, O., Meleshko, T., Sulaieva, O., Hryshchenko, I., Domylivska, L., & Boyko, N. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_5 · Cited by 5
Yang, H., Wei, D., Zhang, Y., & Jian, W. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303257018230927182802 · Cited by 7
Kang, H.-M., Lim, J.-S., & Lee, S. (2021) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2021.28.1.129 · Cited by 4
The influence of the introduction of rice bran on fermented milk drink
Самілик, М. М., Qin, X., & Luo, Y. (2021) · Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies · doi:10.32718/nvlvet-f9608 · Cited by 4
Li, S., Lu, Y., Wang, Q., Zheng, W., Fu, X., Su, Y., & Guan, X. (2026) · Food & Function · doi:10.1039/d5fo05558j · Cited by 4
Kordkatouli, M., Koohsari, H., Maroufi, M., Poli, M. S. S., & Zamani, F. (2025) · Bimonthly Journal of Hormozgan University of Medical Sciences · doi:10.34172/hmj.8408 · Cited by 2
Esembaeva, M. A., Kulyashov, M. A., Sokolova, T. V., Akberdin, I. R., & Sazonov, A. E. (2025) · Metabolites · doi:10.3390/metabo15120767 · Cited by 2
Ma, Y., Yan, S., Dong, Y., Ma, Y., Lai, X., Jin, X., Huang, L., & Qingshen, S. U. N. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10907-6 · Cited by 2
Rovik, A., & Kusharyati, D. F. (2025) · BIO Web of Conferences · doi:10.1051/bioconf/202519001031 · Cited by 2
Lim, J.-S., Park, Y.-H., Jo, B.-S., Kim, J.-E., & Lee, S. (2022) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2022.29.3.472 · Cited by 2
Sankova, M. V., Nikolenko, V. N., Sankov, S. V., & Sinelnikov, M. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00023-2 · Cited by 1
Probiotic Intervention for Human Health and Disease
Bhat, B., & Bajaj, B. K. (2019) · Wiley eBooks · doi:10.1002/9781119555384.ch10
Bourrie, B. C. T. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-p44t-f154
Camel milk affects serum metabolites by modulating the intestinal microfloraPreprint
Yue, H., Zhang, J., Wang, R., Zhao, L., Kou, Y., Li, R., Yang, Z., Qian, Y., Li, X., Wang, X. Q., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.18.572112
Wulandari, F., Rustanti, N., & Pramono, A. (2025) · Medical Laboratory Technology Journal · doi:10.31964/mltj.v11i1.639
Role of Probiotics for the Treatment of Cardiovascular Disease - A Systematic Review
Patil, S., Kulkarni, P. V., & Kulkarni, V. H. (2025) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2025.v85i8.010
Yan, Y., Liu, C., Zhao, S., Wang, X., Wang, J., Zhang, H., Wang, Y., & Zhao, G. (2020) · Figshare · doi:10.6084/m9.figshare.12399182
Probiotic intervention in NAFLD: current progress, challenges, and future potential
Li, H., Wang, W., Hu, X., Chen, H., Chen, L., Lin, S., Yu, C., & Hu, W. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251104 · Cited by 1
Iešmantaitė, M., Usonis, L., Čeika, K., Šimoliūnas, E., Liudvinaitis, M., Soto-Arroyo, N., Moreno-Indias, I., Tinahones, F. J., Baltriukienė, D., & Mela, V. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01206-x
Siqueira, J. S., da Cruz, L. L., Palacio, T. L. N., Cruzeiro, J., Francisqueti‐Ferron, F. V., Aldini, G., D’Amato, A., & Correa, C. R. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110482
Jung, E.-A., Kim, H., YOKOYAMA, W. H., Nitin, N., & Seo, K. (2026) · Journal of Oral Microbiology · doi:10.1080/20002297.2026.2712769
Self-citationThe Gut Microbiota–Muscle Axis: Lactobacillus as a Potential Modulator of Skeletal Muscle Health
Janet, B., Jena, R., Rao, B. S. S., & Dehury, B. (2026) · BioMed Research International · doi:10.1155/bmri/7133290
Akbulut, S. (2026) · Türk doğa ve fen dergisi :/Türk doğa ve fen dergisi · doi:10.46810/tdfd.1955987
Tutun, S., Demir, T., Can, Ö. P., & Erol, Z. (2026) · Revista Científica de la Facultad de Ciencias Veterinarias · doi:10.52973/rcfcv-e3631034
Metadata
- Authors
- Kim, D., Jeong, D., Kang, I., Kim, H., Song, K., & Seo, K.
- Affiliations
- Konkuk University (KR)
- Hanyang University (KR)
- Corresponding author
- Seo, Kun‐Ho
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2017-08-29
- Volume
- 61
- Issue
- 11
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2736229177
- Cited by
- 122
- References
- 44
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 6 · 2023: 14 · 2022: 20 · 2021: 18 · 2020: 21 · 2019: 11 · 2018: 14 · 2017: 3
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Nutrition & Food Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Research Foundation of Korea
- Ministry of Science ICT and Future Planning (2015R1A2A2A01005017)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- Lactobacillus kefiri, kefir, lactic acid bacteria, high-fat diet, obesity prevention, cholesterol lowering, PPARα, adipose tissue, fatty acid oxidation, FABP4, carnitine palmitoyltransferase 1, hepatic steatosis, non-alcoholic fatty liver disease, gut microbiota, triglycerides, LDL cholesterol, probiotics
- MeSH terms
- Kefir, Animals, Carnitine O-Palmitoyltransferase, Cholesterol, Dietary, Feces, Gene Expression Regulation, Hypercholesterolemia, Lactobacillus, Male, Mice, Inbred C57BL, Obesity, Random Allocation, Probiotics, PPAR alpha, Adiposity, Microbial Viability, Fatty Acid-Binding Proteins, Adipose Tissue, White, Republic of Korea, Molecular Typing, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.